There are serious conditions for which we have no cure, so we keep on searching for anything that might help. Which explains why a cough medicine, yes, you read that right, is being tried out for Parkinson’s.
And not just as symptomatic therapy but as a treatment that could slow down its progression.
Researchers led by a team at University College London will soon launch a phase 3 clinical trial with the active ingredient of cough remedies, ambroxol, to assess its effectiveness in hundreds of people with Parkinson’s.
